PMC:7565665 / 74247-75562
Annnotations
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T449","span":{"begin":495,"end":500},"obj":"Body_part"},{"id":"T450","span":{"begin":660,"end":662},"obj":"Body_part"}],"attributes":[{"id":"A449","pred":"fma_id","subj":"T449","obj":"http://purl.org/sig/ont/fma/fma68877"},{"id":"A450","pred":"fma_id","subj":"T450","obj":"http://purl.org/sig/ont/fma/fma66592"}],"text":"The focus on targeting autophagy to treat exacerbations in lieu of antiviral medications is limited but is gaining more interest. One recent study has demonstrated the promise of budesonide, a corticosteroid, in the treatment of rhinovirus infections. Rhinovirus causes the common cold and is a common viral cause of exacerbations in CF [32,175], asthma [32,216], and COPD [32,217]. In this study, researchers found that intranasal budesonide decreased the viral load of rhinovirus in patients’ lungs [218]. The investigators determined the antiviral effect of budesonide was due to autophagy induction as autophagy inhibition with chloroquine and bafilomycin A1 both significantly reduced the antiviral effect of budesonide [218]. Similarly, a study performed with dexamethasone, another corticosteroid, demonstrated that it is an effective treatment of rhinovirus through autophagy induction as well [219]. Thus, there is promise in treating and preventing exacerbations caused by rhinovirus using autophagy-inducing drugs. In theory, targeting the induction of autophagy should provide a therapeutic mechanism for the treatment of other viruses that cause exacerbations in patients with chronic respiratory disease due to the role of autophagy in the immune response in many viruses, yet more research is needed."}
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T508","span":{"begin":240,"end":250},"obj":"Disease"},{"id":"T509","span":{"begin":274,"end":285},"obj":"Disease"},{"id":"T510","span":{"begin":334,"end":336},"obj":"Disease"},{"id":"T511","span":{"begin":347,"end":353},"obj":"Disease"},{"id":"T512","span":{"begin":368,"end":372},"obj":"Disease"},{"id":"T513","span":{"begin":1198,"end":1217},"obj":"Disease"}],"attributes":[{"id":"A508","pred":"mondo_id","subj":"T508","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A509","pred":"mondo_id","subj":"T509","obj":"http://purl.obolibrary.org/obo/MONDO_0005709"},{"id":"A510","pred":"mondo_id","subj":"T510","obj":"http://purl.obolibrary.org/obo/MONDO_0009061"},{"id":"A511","pred":"mondo_id","subj":"T511","obj":"http://purl.obolibrary.org/obo/MONDO_0004979"},{"id":"A512","pred":"mondo_id","subj":"T512","obj":"http://purl.obolibrary.org/obo/MONDO_0005002"},{"id":"A513","pred":"mondo_id","subj":"T513","obj":"http://purl.obolibrary.org/obo/MONDO_0005087"}],"text":"The focus on targeting autophagy to treat exacerbations in lieu of antiviral medications is limited but is gaining more interest. One recent study has demonstrated the promise of budesonide, a corticosteroid, in the treatment of rhinovirus infections. Rhinovirus causes the common cold and is a common viral cause of exacerbations in CF [32,175], asthma [32,216], and COPD [32,217]. In this study, researchers found that intranasal budesonide decreased the viral load of rhinovirus in patients’ lungs [218]. The investigators determined the antiviral effect of budesonide was due to autophagy induction as autophagy inhibition with chloroquine and bafilomycin A1 both significantly reduced the antiviral effect of budesonide [218]. Similarly, a study performed with dexamethasone, another corticosteroid, demonstrated that it is an effective treatment of rhinovirus through autophagy induction as well [219]. Thus, there is promise in treating and preventing exacerbations caused by rhinovirus using autophagy-inducing drugs. In theory, targeting the induction of autophagy should provide a therapeutic mechanism for the treatment of other viruses that cause exacerbations in patients with chronic respiratory disease due to the role of autophagy in the immune response in many viruses, yet more research is needed."}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T843","span":{"begin":4,"end":9},"obj":"http://purl.obolibrary.org/obo/CLO_0009985"},{"id":"T844","span":{"begin":147,"end":150},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T845","span":{"begin":191,"end":192},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T846","span":{"begin":293,"end":294},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T847","span":{"begin":495,"end":500},"obj":"http://www.ebi.ac.uk/efo/EFO_0000934"},{"id":"T848","span":{"begin":743,"end":744},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T849","span":{"begin":903,"end":906},"obj":"http://purl.obolibrary.org/obo/CLO_0001195"},{"id":"T850","span":{"begin":1089,"end":1090},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T851","span":{"begin":1140,"end":1147},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T852","span":{"begin":1278,"end":1285},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"}],"text":"The focus on targeting autophagy to treat exacerbations in lieu of antiviral medications is limited but is gaining more interest. One recent study has demonstrated the promise of budesonide, a corticosteroid, in the treatment of rhinovirus infections. Rhinovirus causes the common cold and is a common viral cause of exacerbations in CF [32,175], asthma [32,216], and COPD [32,217]. In this study, researchers found that intranasal budesonide decreased the viral load of rhinovirus in patients’ lungs [218]. The investigators determined the antiviral effect of budesonide was due to autophagy induction as autophagy inhibition with chloroquine and bafilomycin A1 both significantly reduced the antiviral effect of budesonide [218]. Similarly, a study performed with dexamethasone, another corticosteroid, demonstrated that it is an effective treatment of rhinovirus through autophagy induction as well [219]. Thus, there is promise in treating and preventing exacerbations caused by rhinovirus using autophagy-inducing drugs. In theory, targeting the induction of autophagy should provide a therapeutic mechanism for the treatment of other viruses that cause exacerbations in patients with chronic respiratory disease due to the role of autophagy in the immune response in many viruses, yet more research is needed."}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T208","span":{"begin":67,"end":76},"obj":"Chemical"},{"id":"T57643","span":{"begin":179,"end":189},"obj":"Chemical"},{"id":"T86220","span":{"begin":193,"end":207},"obj":"Chemical"},{"id":"T39526","span":{"begin":432,"end":442},"obj":"Chemical"},{"id":"T39935","span":{"begin":541,"end":550},"obj":"Chemical"},{"id":"T213","span":{"begin":561,"end":571},"obj":"Chemical"},{"id":"T91389","span":{"begin":632,"end":643},"obj":"Chemical"},{"id":"T99571","span":{"begin":648,"end":662},"obj":"Chemical"},{"id":"T87751","span":{"begin":694,"end":703},"obj":"Chemical"},{"id":"T15725","span":{"begin":714,"end":724},"obj":"Chemical"},{"id":"T83295","span":{"begin":766,"end":779},"obj":"Chemical"},{"id":"T78343","span":{"begin":789,"end":803},"obj":"Chemical"},{"id":"T7124","span":{"begin":1019,"end":1024},"obj":"Chemical"}],"attributes":[{"id":"A97229","pred":"chebi_id","subj":"T208","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"},{"id":"A87600","pred":"chebi_id","subj":"T57643","obj":"http://purl.obolibrary.org/obo/CHEBI_3207"},{"id":"A47865","pred":"chebi_id","subj":"T86220","obj":"http://purl.obolibrary.org/obo/CHEBI_50858"},{"id":"A80689","pred":"chebi_id","subj":"T39526","obj":"http://purl.obolibrary.org/obo/CHEBI_3207"},{"id":"A3422","pred":"chebi_id","subj":"T39935","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"},{"id":"A12123","pred":"chebi_id","subj":"T213","obj":"http://purl.obolibrary.org/obo/CHEBI_3207"},{"id":"A27076","pred":"chebi_id","subj":"T91389","obj":"http://purl.obolibrary.org/obo/CHEBI_3638"},{"id":"A31051","pred":"chebi_id","subj":"T99571","obj":"http://purl.obolibrary.org/obo/CHEBI_22689"},{"id":"A52140","pred":"chebi_id","subj":"T87751","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"},{"id":"A31681","pred":"chebi_id","subj":"T15725","obj":"http://purl.obolibrary.org/obo/CHEBI_3207"},{"id":"A11758","pred":"chebi_id","subj":"T83295","obj":"http://purl.obolibrary.org/obo/CHEBI_41879"},{"id":"A2367","pred":"chebi_id","subj":"T78343","obj":"http://purl.obolibrary.org/obo/CHEBI_50858"},{"id":"A3804","pred":"chebi_id","subj":"T7124","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"The focus on targeting autophagy to treat exacerbations in lieu of antiviral medications is limited but is gaining more interest. One recent study has demonstrated the promise of budesonide, a corticosteroid, in the treatment of rhinovirus infections. Rhinovirus causes the common cold and is a common viral cause of exacerbations in CF [32,175], asthma [32,216], and COPD [32,217]. In this study, researchers found that intranasal budesonide decreased the viral load of rhinovirus in patients’ lungs [218]. The investigators determined the antiviral effect of budesonide was due to autophagy induction as autophagy inhibition with chloroquine and bafilomycin A1 both significantly reduced the antiviral effect of budesonide [218]. Similarly, a study performed with dexamethasone, another corticosteroid, demonstrated that it is an effective treatment of rhinovirus through autophagy induction as well [219]. Thus, there is promise in treating and preventing exacerbations caused by rhinovirus using autophagy-inducing drugs. In theory, targeting the induction of autophagy should provide a therapeutic mechanism for the treatment of other viruses that cause exacerbations in patients with chronic respiratory disease due to the role of autophagy in the immune response in many viruses, yet more research is needed."}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"1814","span":{"begin":252,"end":262},"obj":"Species"},{"id":"1815","span":{"begin":471,"end":481},"obj":"Species"},{"id":"1816","span":{"begin":485,"end":493},"obj":"Species"},{"id":"1817","span":{"begin":855,"end":865},"obj":"Species"},{"id":"1818","span":{"begin":983,"end":993},"obj":"Species"},{"id":"1819","span":{"begin":1176,"end":1184},"obj":"Species"},{"id":"1820","span":{"begin":179,"end":189},"obj":"Chemical"},{"id":"1821","span":{"begin":432,"end":442},"obj":"Chemical"},{"id":"1822","span":{"begin":561,"end":571},"obj":"Chemical"},{"id":"1823","span":{"begin":632,"end":643},"obj":"Chemical"},{"id":"1824","span":{"begin":648,"end":662},"obj":"Chemical"},{"id":"1825","span":{"begin":714,"end":724},"obj":"Chemical"},{"id":"1826","span":{"begin":766,"end":779},"obj":"Chemical"},{"id":"1827","span":{"begin":229,"end":250},"obj":"Disease"},{"id":"1828","span":{"begin":281,"end":285},"obj":"Disease"},{"id":"1829","span":{"begin":347,"end":353},"obj":"Disease"},{"id":"1830","span":{"begin":368,"end":372},"obj":"Disease"},{"id":"1831","span":{"begin":1198,"end":1217},"obj":"Disease"}],"attributes":[{"id":"A1814","pred":"tao:has_database_id","subj":"1814","obj":"Tax:12059"},{"id":"A1815","pred":"tao:has_database_id","subj":"1815","obj":"Tax:12059"},{"id":"A1816","pred":"tao:has_database_id","subj":"1816","obj":"Tax:9606"},{"id":"A1817","pred":"tao:has_database_id","subj":"1817","obj":"Tax:12059"},{"id":"A1818","pred":"tao:has_database_id","subj":"1818","obj":"Tax:12059"},{"id":"A1819","pred":"tao:has_database_id","subj":"1819","obj":"Tax:9606"},{"id":"A1820","pred":"tao:has_database_id","subj":"1820","obj":"MESH:D019819"},{"id":"A1821","pred":"tao:has_database_id","subj":"1821","obj":"MESH:D019819"},{"id":"A1822","pred":"tao:has_database_id","subj":"1822","obj":"MESH:D019819"},{"id":"A1823","pred":"tao:has_database_id","subj":"1823","obj":"MESH:D002738"},{"id":"A1824","pred":"tao:has_database_id","subj":"1824","obj":"MESH:C040929"},{"id":"A1825","pred":"tao:has_database_id","subj":"1825","obj":"MESH:D019819"},{"id":"A1826","pred":"tao:has_database_id","subj":"1826","obj":"MESH:D003907"},{"id":"A1827","pred":"tao:has_database_id","subj":"1827","obj":"MESH:D007239"},{"id":"A1828","pred":"tao:has_database_id","subj":"1828","obj":"MESH:D000067390"},{"id":"A1829","pred":"tao:has_database_id","subj":"1829","obj":"MESH:D001249"},{"id":"A1830","pred":"tao:has_database_id","subj":"1830","obj":"MESH:D029424"},{"id":"A1831","pred":"tao:has_database_id","subj":"1831","obj":"MESH:D012140"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"The focus on targeting autophagy to treat exacerbations in lieu of antiviral medications is limited but is gaining more interest. One recent study has demonstrated the promise of budesonide, a corticosteroid, in the treatment of rhinovirus infections. Rhinovirus causes the common cold and is a common viral cause of exacerbations in CF [32,175], asthma [32,216], and COPD [32,217]. In this study, researchers found that intranasal budesonide decreased the viral load of rhinovirus in patients’ lungs [218]. The investigators determined the antiviral effect of budesonide was due to autophagy induction as autophagy inhibition with chloroquine and bafilomycin A1 both significantly reduced the antiviral effect of budesonide [218]. Similarly, a study performed with dexamethasone, another corticosteroid, demonstrated that it is an effective treatment of rhinovirus through autophagy induction as well [219]. Thus, there is promise in treating and preventing exacerbations caused by rhinovirus using autophagy-inducing drugs. In theory, targeting the induction of autophagy should provide a therapeutic mechanism for the treatment of other viruses that cause exacerbations in patients with chronic respiratory disease due to the role of autophagy in the immune response in many viruses, yet more research is needed."}
LitCovid-PD-HP
{"project":"LitCovid-PD-HP","denotations":[{"id":"T215","span":{"begin":347,"end":353},"obj":"Phenotype"},{"id":"T216","span":{"begin":368,"end":372},"obj":"Phenotype"}],"attributes":[{"id":"A215","pred":"hp_id","subj":"T215","obj":"http://purl.obolibrary.org/obo/HP_0002099"},{"id":"A216","pred":"hp_id","subj":"T216","obj":"http://purl.obolibrary.org/obo/HP_0006510"}],"text":"The focus on targeting autophagy to treat exacerbations in lieu of antiviral medications is limited but is gaining more interest. One recent study has demonstrated the promise of budesonide, a corticosteroid, in the treatment of rhinovirus infections. Rhinovirus causes the common cold and is a common viral cause of exacerbations in CF [32,175], asthma [32,216], and COPD [32,217]. In this study, researchers found that intranasal budesonide decreased the viral load of rhinovirus in patients’ lungs [218]. The investigators determined the antiviral effect of budesonide was due to autophagy induction as autophagy inhibition with chloroquine and bafilomycin A1 both significantly reduced the antiviral effect of budesonide [218]. Similarly, a study performed with dexamethasone, another corticosteroid, demonstrated that it is an effective treatment of rhinovirus through autophagy induction as well [219]. Thus, there is promise in treating and preventing exacerbations caused by rhinovirus using autophagy-inducing drugs. In theory, targeting the induction of autophagy should provide a therapeutic mechanism for the treatment of other viruses that cause exacerbations in patients with chronic respiratory disease due to the role of autophagy in the immune response in many viruses, yet more research is needed."}
LitCovid-PD-GO-BP
{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T955","span":{"begin":23,"end":32},"obj":"http://purl.obolibrary.org/obo/GO_0016236"},{"id":"T956","span":{"begin":23,"end":32},"obj":"http://purl.obolibrary.org/obo/GO_0006914"},{"id":"T957","span":{"begin":583,"end":592},"obj":"http://purl.obolibrary.org/obo/GO_0016236"},{"id":"T958","span":{"begin":583,"end":592},"obj":"http://purl.obolibrary.org/obo/GO_0006914"},{"id":"T959","span":{"begin":606,"end":615},"obj":"http://purl.obolibrary.org/obo/GO_0016236"},{"id":"T960","span":{"begin":606,"end":615},"obj":"http://purl.obolibrary.org/obo/GO_0006914"},{"id":"T961","span":{"begin":874,"end":883},"obj":"http://purl.obolibrary.org/obo/GO_0016236"},{"id":"T962","span":{"begin":874,"end":883},"obj":"http://purl.obolibrary.org/obo/GO_0006914"},{"id":"T963","span":{"begin":1000,"end":1009},"obj":"http://purl.obolibrary.org/obo/GO_0016236"},{"id":"T964","span":{"begin":1000,"end":1009},"obj":"http://purl.obolibrary.org/obo/GO_0006914"},{"id":"T965","span":{"begin":1064,"end":1073},"obj":"http://purl.obolibrary.org/obo/GO_0016236"},{"id":"T966","span":{"begin":1064,"end":1073},"obj":"http://purl.obolibrary.org/obo/GO_0006914"},{"id":"T967","span":{"begin":1237,"end":1246},"obj":"http://purl.obolibrary.org/obo/GO_0016236"},{"id":"T968","span":{"begin":1237,"end":1246},"obj":"http://purl.obolibrary.org/obo/GO_0006914"},{"id":"T969","span":{"begin":1254,"end":1269},"obj":"http://purl.obolibrary.org/obo/GO_0006955"}],"text":"The focus on targeting autophagy to treat exacerbations in lieu of antiviral medications is limited but is gaining more interest. One recent study has demonstrated the promise of budesonide, a corticosteroid, in the treatment of rhinovirus infections. Rhinovirus causes the common cold and is a common viral cause of exacerbations in CF [32,175], asthma [32,216], and COPD [32,217]. In this study, researchers found that intranasal budesonide decreased the viral load of rhinovirus in patients’ lungs [218]. The investigators determined the antiviral effect of budesonide was due to autophagy induction as autophagy inhibition with chloroquine and bafilomycin A1 both significantly reduced the antiviral effect of budesonide [218]. Similarly, a study performed with dexamethasone, another corticosteroid, demonstrated that it is an effective treatment of rhinovirus through autophagy induction as well [219]. Thus, there is promise in treating and preventing exacerbations caused by rhinovirus using autophagy-inducing drugs. In theory, targeting the induction of autophagy should provide a therapeutic mechanism for the treatment of other viruses that cause exacerbations in patients with chronic respiratory disease due to the role of autophagy in the immune response in many viruses, yet more research is needed."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T393","span":{"begin":0,"end":129},"obj":"Sentence"},{"id":"T394","span":{"begin":130,"end":251},"obj":"Sentence"},{"id":"T395","span":{"begin":252,"end":382},"obj":"Sentence"},{"id":"T396","span":{"begin":383,"end":507},"obj":"Sentence"},{"id":"T397","span":{"begin":508,"end":731},"obj":"Sentence"},{"id":"T398","span":{"begin":732,"end":908},"obj":"Sentence"},{"id":"T399","span":{"begin":909,"end":1025},"obj":"Sentence"},{"id":"T400","span":{"begin":1026,"end":1315},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The focus on targeting autophagy to treat exacerbations in lieu of antiviral medications is limited but is gaining more interest. One recent study has demonstrated the promise of budesonide, a corticosteroid, in the treatment of rhinovirus infections. Rhinovirus causes the common cold and is a common viral cause of exacerbations in CF [32,175], asthma [32,216], and COPD [32,217]. In this study, researchers found that intranasal budesonide decreased the viral load of rhinovirus in patients’ lungs [218]. The investigators determined the antiviral effect of budesonide was due to autophagy induction as autophagy inhibition with chloroquine and bafilomycin A1 both significantly reduced the antiviral effect of budesonide [218]. Similarly, a study performed with dexamethasone, another corticosteroid, demonstrated that it is an effective treatment of rhinovirus through autophagy induction as well [219]. Thus, there is promise in treating and preventing exacerbations caused by rhinovirus using autophagy-inducing drugs. In theory, targeting the induction of autophagy should provide a therapeutic mechanism for the treatment of other viruses that cause exacerbations in patients with chronic respiratory disease due to the role of autophagy in the immune response in many viruses, yet more research is needed."}